Cargando…
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213973/ https://www.ncbi.nlm.nih.gov/pubmed/32440185 http://dx.doi.org/10.2147/CCID.S249776 |
_version_ | 1783531891613237248 |
---|---|
author | Ezzedine, Khaled Fougerousse, Anne Claire Aubert, Roberte Monfort, Jean-Benoît Reguiaï, Ziad Shourick, Jason Taieb, Charles Maccari, François |
author_facet | Ezzedine, Khaled Fougerousse, Anne Claire Aubert, Roberte Monfort, Jean-Benoît Reguiaï, Ziad Shourick, Jason Taieb, Charles Maccari, François |
author_sort | Ezzedine, Khaled |
collection | PubMed |
description | BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing quality of life issues. The questionnaire was translated from French into a cultural and linguistically validated US English version. RESULTS: A conceptual questionnaire of 54 questions was created. The confirmatory analyses resulted in a 10-feature questionnaire divided into 4 internally consistent domains with a Cronbach’s alpha coefficient of 0.9. It was reproducible and highly reliable. It correlated well with the Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), and SF-12 mental and SF12 physical scores. CONCLUSION: This tool allows for the first time to assess the burden of psoriasis patients. Its use may allow improving medical and nonmedical patient care, thus improving their daily life. |
format | Online Article Text |
id | pubmed-7213973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-72139732020-05-21 Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis Ezzedine, Khaled Fougerousse, Anne Claire Aubert, Roberte Monfort, Jean-Benoît Reguiaï, Ziad Shourick, Jason Taieb, Charles Maccari, François Clin Cosmet Investig Dermatol Methodology BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing quality of life issues. The questionnaire was translated from French into a cultural and linguistically validated US English version. RESULTS: A conceptual questionnaire of 54 questions was created. The confirmatory analyses resulted in a 10-feature questionnaire divided into 4 internally consistent domains with a Cronbach’s alpha coefficient of 0.9. It was reproducible and highly reliable. It correlated well with the Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), and SF-12 mental and SF12 physical scores. CONCLUSION: This tool allows for the first time to assess the burden of psoriasis patients. Its use may allow improving medical and nonmedical patient care, thus improving their daily life. Dove 2020-05-04 /pmc/articles/PMC7213973/ /pubmed/32440185 http://dx.doi.org/10.2147/CCID.S249776 Text en © 2020 Ezzedine et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Methodology Ezzedine, Khaled Fougerousse, Anne Claire Aubert, Roberte Monfort, Jean-Benoît Reguiaï, Ziad Shourick, Jason Taieb, Charles Maccari, François Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title | Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title_full | Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title_fullStr | Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title_full_unstemmed | Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title_short | Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis |
title_sort | individual burden of psoriasis (i-bop): building and validation of a new scoring tool for patients with psoriasis |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213973/ https://www.ncbi.nlm.nih.gov/pubmed/32440185 http://dx.doi.org/10.2147/CCID.S249776 |
work_keys_str_mv | AT ezzedinekhaled individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT fougerousseanneclaire individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT aubertroberte individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT monfortjeanbenoit individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT reguiaiziad individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT shourickjason individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT taiebcharles individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis AT maccarifrancois individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis |